dkNET community events and announcements in November, 2022
- 05:36pm November 4, 2022
- Ko-Wei Lin
Dear dkNET Community,
dkNET provides updates on activities of interest to the NIDDK-supported community. You could keep up to date on these activities through our Twitter feed @dkNET_info, through our Community Calendar, or through dkNET e-mail list. If you have an event or funding opportunities you'd like to advertise, please contact us info_at_dknet.org.
dkNET News
- dkNET Upcoming Webinars:
- Come join us for a webinar presented by MacKenzie Brandes on Friday, November 18, 2022 at 11 am - 12 pm PT to learn about the Accelerating Medicine Partnership Common Metabolic Diseases Knowledge Portal, a resource for research into the genetic and genomic basis of diabetes and cardiometabolic diseases! Register it now: https://dknet.org/about/blog/2512
- Dr. Monica Westley, Tiffany Richardson, Neha Majety will give a webinar presentation "The Mission and Progress of the(sugar)science: Helping Scientists Who Study Type 1 Diabetes Connect" on Friday, December 9, 2022, 11 am PT, Join us to learn more about the(sugar)science! https://dknet.org/about/blog/2525
Events in November 2022
Nov. 01-04, 2022
Obesity Week 2022
The preeminent international conference for obesity researchers and clinicians, ObesityWeek® is home to the latest developments in evidence-based obesity science: cutting-edge basic and clinical research, state-of-the-art obesity treatment and prevention, and the latest efforts in advocacy and public policy. Overcoming obesity requires multi-disciplinary approaches. This is the conference that encompasses the full spectrum of obesity science: from basic science research, to translational research and clinical application, to public policy; from diet, exercise, lifestyle, and psychology to medical and surgical interventions; from pediatric to geriatric to underserved populations. ObesityWeek® 2022 will be a hybrid conference.
Conference Dates: November 1-4, 2022
Obesity Journal Symposium Submission Deadline: June 15, 2022
Location: San Diego, CA, USA
More Information: https://obesityweek.org/
AASLD The Liver Meeting
Programming at The Liver Meeting will primarily be delivered live in person, with some sessions live-streamed to the TLMdX platform. Sessions will be captured and made available on the platform within 72 hours, or sooner, of their in-person delivery. Some educational content will also be available on-demand at the start of the meeting. Attendees can anticipate:
- The latest research on disease states like NAFLD, NASH, Hepatitis and much more.
- Educational sessions from leading hepatologists and public health experts from around the globe on the effects of the COVID-19 virus from both clinical and public health perspectives.
- The specialty’s leading minds in our popular Meet-the-Expert sessions.
- Ample opportunities to connect with your peers.
- The patient perspective provided by special Patient Advocacy Group programming.
- All educational programming will be available on the platform through February 2023
Location: Washington, DC, USA
More information: https://www.aasld.org/the-liver-meeting
Nov. 07-11, 2022
MMPC Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis
14th Annual Course - Isotope Tracers in Metabolic Research: Principles and Practice of Kinetic Analysis
A week-long course (with one-on-one mentoring sessions) in the theory and practice of stable and radioactive isotopic tracers for the study of metabolism in human and animal models. This course provides basic introductory and comprehensive information on performing metabolic studies using tracers labeled with radioactive or stable isotopes in humans, animals and cells. The course is designed for beginners as well as for those with experience who wish to expand their capabilities to more sophisticated problems.
Course Dates: November 7-11, 2022
Registration Opens: June 1, 2022
Location: Nashville, TN, USA
NIDDK Workshop Registration Due: Workshop on Housing and Obesity: Gaps, Opportunities, and Future Directions for Advancing Health Equity
The overall goal of this workshop is to accelerate research on the role of housing insecurity—including housing affordability, quality, stability, and its neighborhood context— on behaviors and pathways underlying risk for obesity-related health disparities across the lifespan. The workshop will emphasize existing research that connects housing policies and programs with obesity and also address methods for housing and obesity research, including study design, measures, data linkages and analytic approaches. The event will highlight interventions focused on addressing housing as a social need and that also move upstream to address housing as a core social determinant of health. The workshop will include engaging and interactive discussions to identify key research questions for advancing health equity research priorities relevant to diverse sectors and identify opportunities to create research partnerships and collaborations across Federal, regional and local housing programs. The workshop is a two-day, online event and is free and open to the public. The meeting will bring together a diverse group researchers, leaders, and experts from a range of disciplines, including housing, obesity, health disparities, health equity, public health, and other relevant fields. The event will feature panel presentations, poster sessions, breakout sessions, and interactive discussions. Registration is required.
Registration Deadline: November 9, 2022
Workshop Dates: November 14-15, 2022
More Information: https://www.niddk.nih.gov/news/meetings-workshops/2022/workshop-housing-obesityDiabetes Research Centers Virtual Seminar Series Panel Discussion: 90-minute Panel with Q&A
Speakers:
Amber, L. Alhadeff, PhD, Principal Investigator, Monell Chemical Senses Center, Dept. of Neuroscience, University Of Pennsylvania. “Nutrient sensing along the gut-brain axis”
Josh Thaler, PhD, Associate Professor, University of Washington. “The Metabolic impact of Microglial Activation”
More Information: https://diabetes-virtual-seminar.org/
NIH Webinar: How to include generalist repositories in your NIH data management and sharing plans
Learn how to include generalist repositories in data sharing plans as part of your preparation for the new NIH Data Management and Sharing Policy beginning in January 2023. This webinar will include guidance on selecting a generalist repository, using generalist repositories jointly with discipline-specific repositories, describing plans to use a generalist repository in a Data Management and Sharing Plan, and preparing for data sharing and reporting.
Speakers: Julie Goldman (Dataverse, Harvard Library), Sarah Lippincott (Dryad), Nici Pfeiffer (Open Science Framework), Rebecca Li (Vivli)Moderated by: Ana Van Gulick (Figshare)
Webinar Date: November 10, 2022 12:00 PM PT
Other NIH Generalist Repository Ecosystem Initiative (GREI) Webinar Dates: September 15, October 12, & December 8
More Information: https://datascience.nih.gov/grei-collaborative-webinar-series
Nov. 10, 2022
HIRN Webinar: Pancreatlas™: Mapping the Human Pancreas in Health and Disease
Topics to be Discussed:
* Introduction to Pancreatlas Platform
* Overview of Global Search Function and Harmonized Metadata
* Integration of Images Across HPAP, HANDEL-P, nPOD & IIDP
Presentations by:
Marcela Brissova, PhD, Vanderbilt University
Jean-Philippe Cartailler, PhD, Vanderbilt University
Diane Saunders, PhD, Vanderbilt University
More information: https://cityofhope.zoom.us/meeting/register/tJMld-mgpjgqHdHrkW0hmZeqVY7MG56yAnR0
Nov. 11, 2022
Endocrine Society Meeting "Achieving Higher-Resolution in Neuroendocrinology"
This new half-day meeting is designed for basic scientists at all career stages who are interested in the latest technologies that can be applied to neuroendocrine research. Participants will be able to share research with a focus on innovative techniques and novel approaches of interest to neuroscientists and endocrine scientists. This event, which is free to attend, will feature a symposium with a keynote address followed by a poster session and reception. Abstracts submitted for poster presentations will be considered for one of two short talks.
Meeting Date: November 11, 2022
Abstract Submission Deadline: October 14, 2022
Location: San Diego, CA, USA
Neuroscience 2022
Neuroscience 2022 will be held in-person in San Diego, CA, November 12-16. SfN is also exploring options for a virtual presentation for those abstract presenters unable to attend the meeting in-person. More details will be available in May. Each year, scientists from around the world congregate to discover new ideas, share their research, and experience the best the field has to offer. Attend so you can: present research, network with scientists, attend session and events, and browse the exhibit hall.
Abstract Submission Deadline: June 15, 2022
Advance Registration Deadline: October 3, 2022
Conference Dates: November 12-16, 2022
Location: San Diego, CA, USA
More Information: https://www.sfn.org/meetings/neuroscience-2022
NIDDK Workshop: Workshop on Housing and Obesity: Gaps, Opportunities, and Future Directions for Advancing Health Equity
The overall goal of this workshop is to accelerate research on the role of housing insecurity—including housing affordability, quality, stability, and its neighborhood context— on behaviors and pathways underlying risk for obesity-related health disparities across the lifespan. The workshop will emphasize existing research that connects housing policies and programs with obesity and also address methods for housing and obesity research, including study design, measures, data linkages and analytic approaches. The event will highlight interventions focused on addressing housing as a social need and that also move upstream to address housing as a core social determinant of health. The workshop will include engaging and interactive discussions to identify key research questions for advancing health equity research priorities relevant to diverse sectors and identify opportunities to create research partnerships and collaborations across Federal, regional and local housing programs. The workshop is a two-day, online event and is free and open to the public. The meeting will bring together a diverse group researchers, leaders, and experts from a range of disciplines, including housing, obesity, health disparities, health equity, public health, and other relevant fields. The event will feature panel presentations, poster sessions, breakout sessions, and interactive discussions. Registration is required.
Registration Deadline: November 9, 2022
Workshop Dates: November 14-15, 2022
More Information: https://www.niddk.nih.gov/news/meetings-workshops/2022/workshop-housing-obesity
LIPID MAPS Webinar: "Formation, structural characterization, and quantification of endogenous nitrated fatty acids."
Francisco Schopfer is an Associate Professor and Vice-Chair for Biotechnology Development in the Department of Pharmacology and Chemical Biology, University of Pittsburgh. His long-term research interests are the formation, signaling, and metabolism of electrophilic fatty acids. His laboratory focuses on lipid substrates used for fatty acid nitration, the chemical mechanism of nitrated fatty acid formation, and their reactivity with thiols to modulate signaling. Schopfer developed mass spectrometry methods to characterize nitrated fatty acids in vivo and validated quantification methods for clinical evaluation. Given these lipids' potent anti-inflammatory, protective and anti-fibrotic properties, he worked on translating these findings into the clinic with the prototypical nitrated oleic acid being evaluated in Phase II clinical trials.
Presenter: Assoc. Professor Francisco Schopfer
Webinar Date: November 15, 2022 at 9:00AM PST
More Information: https://www.lipidmaps.org/resources/webinars/30
Nov. 15, 2022
NIH ODSS Data Curation Network Event: Applying the CURATE(D) Model for Data Curation
This virtual workshop, geared toward researchers and information professionals, will provide an overview of appraising and preparing research data for the purpose of data sharing through the Data Curation Network’s CURATE(D) model. During this half-day learning opportunity, attendees will:
- Increase their understanding of data curation practices to make data more Findable, Accessible, Interoperable, and Reusable (FAIR).
- Apply the CURATE(D) model to a data deposit.
- Meet like-minded colleagues who are interested in developing or enhancing curation practices at their institutions.
This will be an interactive workshop with breakout rooms and small group activities. Attendees will need access to appropriate technology (computer, microphone, webcam, speakers/headphones, web browsers, high speed internet) and come prepared to participate.
More information: https://datascience.nih.gov/data-curation-network-event-series
19th Annual Chicago Biomedical Consortium Symposium: Stress and Human Health: Diabetes
FULL DAY HYBRID EVENT:VIRTUAL AND IN-PERSON IN CHICAGO
DATE: Thursday, November 17, 2022
LOCATION:
Northwestern Medicine Prentice Women’s Hospital
Room L and Harris Atrium
250 E. Superior Street, Chicago, IL 60611
AND virtually as a ZOOM Webinar.
TIME: 8:30 AM – 6:30 PM
POSTER SESSION: 11:45 AM – 1:00 PM
Location: Chicago, IL, USA
More Information: https://chicagobiomedicalconsortium.org/education/symposia/symposia-2022/
Nov. 18, 2022
dkNET Webinar "The Accelerating Medicines Partnership Common Metabolic Diseases Knowledge Portal: A Resource For Research Into The Genetic And Genomic Basis Of Diabetes And Cardiometabolic Disease"
Abstract
Common metabolic diseases are complex, as many genetic loci influencing disease risk have been identified to date. Discovering the genes and biological mechanisms through which these variants impact specific diseases requires the integration of multiple data types. We have created the Common Metabolic Diseases Knowledge Portal (CMDKP; hugeamp.org) to promote understanding and treatment of common metabolic diseases. The CMDKP aggregates and integrates multiple data types for 433 traits: full GWAS summary statistics from over 400 datasets, many of which are not available elsewhere; tissue-specific epigenomic annotations from over 5,500 datasets, via the Common Metabolic Diseases Genome Atlas (CMDGA; cmdga.org); manually curated credible sets; and multiple expert-generated effector gene lists. Bioinformatic methods are implemented at scale across these data: novel sample overlap-aware genetic association meta/analysis meta-analysis; predictions of variant effects (VEP and BASSETT), gene-level association analysis (MAGMA); credible set calculations; and annotation global enrichments (GREGOR and S-LDSC). The integrated results are accessible via an open-access web portal, which offers both forward and reverse genetics workflows, with results publicly available through direct download and programmatic APIs. In a forward genetics approach, researchers can query a trait or disease and see genome-wide variant- and gene-level genetic associations and tissue-specific epigenomic annotations that are globally enriched for those genetic associations. In a reverse genetics approach, the Region, Gene, and Variant pages distill and summarize results for a gene or variant of interest. Interactive tools allow researchers to perform custom, on-the-fly analyses, such as generating gene-level association scores based on protected individual-level data and assessing the weight of genetic evidence linking a gene to disease. The Variant Sifter visualizer allows users to explore, filter, and prioritize genetically associated variants, credible sets, and tissue-specific epigenomic annotations across a region, providing decision support for the prioritization of variants and genes for further research. We work directly with researchers to create community portals that showcase the results and methods deemed most valuable by each disease research community. In addition, we have created the Bring Your Own Results (BYOR) software service, which offers an auto-generated sortable data table, data filters, and visualizers, and allows individual researchers to easily and rapidly create web pages or portals to share results with reviewers, collaborators, or the public. Collaborations are welcome; please contact help@kp4cd.org.
The top 3 key questions that AMP-CMDKP can answer:1. What genes are associated with chronic kidney disease?
2. Which tissues are most relevant for my disease or trait of interest?
3. What are the curated effector gene predictions for type 1 diabetes?
Presenter: MacKenzie Brandes, Project Manager, Broad Institute
Dial-in Information: https://uchealth.zoom.us/meeting/register/tZEqd-6gpjosE9YJ9zVw5NdUJNtCKGYh_G4c
Date/Time: Friday, November 18, 2022, 11 am - 12 pm PT
2022 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium
The 2022 Rachmiel Levine-Arthur Riggs Diabetes Research Symposium is designed to provide information on new advances in diabetes research, highlighting beta cells, immunology, metabolism, genetics and epigenetics.
Conference Dates: November 29-December 2, 2022
Early bird Registration Deadline: November 1, 2022
Location: Pasadena, CA, USA
CAIRIBU 2022 Annual Meeting
The purpose of the annual CAIRIBU meeting is to bring together the Directors and research teams of the NIDDK U54 O’Brien Urology Centers, the P20 Exploratory Centers for Interdisciplinary Research in Benign Urology, and the Multidisciplinary K12 Urologic Research (KURe) and Urological Epidemiology (KEpi) Institutional Research Career Development Programs. Collectively, these Centers and Programs are part of the CAIRIBU umbrella – Collaborating for the Advancement of Interdisciplinary Research in Benign Urology. The annual meeting allows for the exchange of scientific knowledge about advances in benign genitourinary research and provides a platform for building interactions between CAIRIBU Centers and Programs and between CAIRIBU investigators and the broader benign urologic research community. Primary objectives of the meeting include sharing research resources and advancing students and early investigators in their development as future leaders in the field of benign urology. Interactive poster sessions during the meeting will feature the work of trainees and early-stage investigators whose abstracts are selected for presentation.
Meeting Dates: November 30 - December 2, 2022
Registration Deadline: November 29, 2022
Abstract Deadline: October 19, 2022
More Information: https://www.niddk.nih.gov/news/meetings-workshops/2022/cairibu-2022-annual-meeting
Funding Opportunities Information and Deadlines in November 2022
NIDDK Funding Opportunity Letter of Intent Due: National Coordinating Center for the George M. O’Brien Kidney National Resource Centers (U24 - Clinical Trial Not Allowed)
The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the George M. O’Brien Kidney Consortium -- National Coordination Center (NCC) to lead a nation-wide effort to advance kidney research. The O’Brien Kidney Consortium will consist of ~8 National Resource Centers (NRCs) tasked with developing and sharing specialized kidney resources tools, technologies, services, and expertise and one NCC to lead, manage, and harmonize all aspects of the Consortium. Specifically, the NCC will: (1) provide administrative support and coordination for the entire Consortium, (2) establish and curate a “one-stop-shop” sharing portal for the entire Consortium, (3) develop and implement a multipronged communication and education plan for researchers and students interested in conducting kidney research to maximize national outreach and impact, (4) ensure that patient viewpoints, priorities, and preferences inform all aspects of the Consortium, and (5) administer and manage a national Opportunity Pool program to address gaps and promote collaboration.
Letter of Intent Deadline: November 1, 2022
Application Deadline: December 1, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-008.html
Nov. 02, 2022
NIDDK Funding Opportunity Application Due: High Impact, Interdisciplinary Science in NIDDK Research Areas (RC2 Clinical Trial Optional)
The purpose of the High Impact, Interdisciplinary Science grants program is to support high impact ideas that may lay the foundation for new fields of investigation within the mission of NIDDK. The interdisciplinary approach encouraged by this FOA is envisioned to generate a research resource and/or foster discovery-based or hypothesis-generating science that can have a significant impact on the broader scientific community. This FOA seeks novel approaches in areas that address specific knowledge gaps, scientific opportunities, new technologies, data generation, or research methods that will advance the area in significant ways designed to accelerate scientific progress in the understanding, treatment, and prevention of diseases within the mission of the NIDDK.
Letter of Intent Deadline: Six weeks prior to the application due date.
Application Deadline: June 01, 2022; November 02, 2022
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-069.htmlNov. 02, 2022
NIH Funding Opportunity Letter of Intent Due: Maternal Health Research Centers of Excellence Data Innovation and Coordinating Hub/Resource Center (U24 Clinical Trial Not Allowed)
This Funding Opportunity Announcement (FOA) seeks applications for the Data Innovation and Coordinating Hub/Resource Center (hereafter referred to as “the Innovation Hub”) for the Maternal Health Research Centers of Excellence initiative. This FOA runs in parallel with companion FOAs that seek applications for Research Centers of Excellence (RFA-HD-23-035) and an Implementation Science Hub/Resource Center (RFA-HD-23-037). It is expected that the Data Innovation Hub will provide 1) a coordination infrastructure to foster communication and collaboration for participating Research Centers and the Implementation Science Hub under the Maternal Health Centers of Excellence initiative, 2) Support data collection, facilitate data curation, and ensure high-quality data is shared with Centers of Excellence researchers and submitted to public repositories when appropriate, and 3) provide cutting edge biomedical research informatics and data science expertise to maximize data comparability and facilitate data harmonization. The Data Innovation Hub itself will not generate new experimental data, but rather will serve as a resource, analysis tools, and portal for available analytical and data tools.
Letter of Intent Deadline: November 2, 2022
Application Deadline: December 5, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-hd-23-036.html
Nov. 02, 2022
NIH Funding Opportunity Letter of Intent Due: Maternal Health Research Centers of Excellence (U54 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) invites applications to participate as a Research Center as part of the Maternal Health Research Centers of Excellence initiative. The purpose of this initiative is to generate innovative approaches to address preventable maternal mortality, decrease severe maternal morbidity, and promote maternal health equity in partnership with one or more populations that experience maternal health disparities, including but not limited to, Blacks/African Americans, Hispanics/Latinos, American Indians/Alaska Natives, Asian Americans, Native Hawaiians and other Pacific Islanders, socioeconomically disadvantaged populations, underserved rural populations (e.g., living in maternity care deserts), or sexual and gender minority (SGM) populations. Persons with disabilities are also a priority population. This initiative will use an integrated multi-level approach encompassing structural, social, and biobehavioral research strategies to address the multiple contributing factors that lead to adverse maternal health outcomes and health disparities. Significant contributing factors include comorbid conditions (e.g., hypertension, diabetes, cerebrovascular disease, chronic stress, immune-mediated diseases, sleep disorders, organ-specific diseases, mental illness, and substance use disorders) and structural and social determinants of health, which include but not limited to structural racism and health care system factors.
Letter of Intent Deadline: November 2, 2022
Application Deadline: December 5, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-hd-23-035.htmlNov. 04, 2022
NIH Funding Opportunity Application Due: HEAL Initiative: Development and Validation of Non-Rodent Mammalian Models of Pain (R01 Clinical Trial Not Allowed)
This funding opportunity announcement (FOA) invites research to develop, characterize, and rigorously validate non-rodent mammalian models of pain, associated outcome measures and/or endpoints that will significantly advance translational research for effective pain management. These models are expected to recapitulate molecular, cellular, pathological, behavioral, and/or cognitive aspects of human pain disorders and conditions. Research supported under this FOA is expected to provide well-validated models and measures that facilitate the development of non-opioid analgesic therapeutic interventions with little or no addiction liability.
Letter of Intent Deadline: 30 days prior to the application due date
Application Deadline(s): November 04, 2022 ; March 07, 2023 ; (...)
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-ns-22-070.html
NIDDK Funding Opportunity Application Due: NIDDK Research Education Program Utilizing Stimulating Peripheral Activity to Relieve Conditions (SPARC) - Generated Resources (R25 Clinical Trial Not Allowed) Application Due Date
Description: The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs.To accomplish the stated over-arching goal, this FOA will support creative educational activities with a primary focus on: Research Experiences; Courses for Skills Development. This Funding Opportunity Announcement (FOA) invites applications to establish research programs for qualified graduate students, post-doctoral fellows, medicalresidents, biomedical engineers, and clinical fellows to engage in neuroscience research experiences relevant to the mission of NIDDK and its partnership with the Common Fund program, Stimulating Peripheral Activity to Relieve Conditions (SPARC). The intent is to leverage this partnership to provide resources for short-term research experiences that would necessarily use SPARC-generated resources (datasets/maps/models) as the foundation for the research experience in conjunction with educational activities that may be combined with hands-on computational or ‘wet lab’ projects. The goal is that the research experiences will be impactful and ideally develop new skills and produce new knowledge that could sustain future NIDDK-funded research careers.
Letter of Intent Deadline: October 9, 2022
Application Deadline: November 9, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-20-020.html
Nov. 09, 2022
NIH Funding Opportunity Letter of Intent Due: Maternal Health Research Centers of Excellence Implementation Science Hub/Resource Center (U24 Clinical Trial Optional)
This Funding Opportunity Announcement (FOA) seeks applications for the Implementation Science Hub/Resource Center for the Maternal Health Research Centers of Excellence initiative. This FOA runs in parallel with companion FOAs that seek applications for Research Centers of Excellence (RFA-HD-23-035) and a Data Innovation and Coordinating Hub/Resource Center (RFA-HD-23-036). It is expected that the Implementation Science Hub will serve as a resource to Research Centers, with a particular emphasis on assisting in implementing evidence-informed programs, practices and policies to improve maternal health outcomes. The Implementation Science Hub will help bridge the evidence-to-practice gap to support the development and implementation of strategies to inform integrated efforts involving policy and practice changes to improve pregnancy, perinatal, and postpartum care and advance maternal health and maternal health equity. It is also expected that the Implementation Science/Resource Hub work collaboratively with the Data Innovation and Coordination Hub/Resource Center.
Letter of Intent Deadline: November 9, 2022
Application Deadline: December 5, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-hd-23-037.html
NIH Funding Opportunity Application Due: Platform Clinical Trials of Genome Editors in Multiple Diseases (UG3/UH3, Clinical Trial Required)
The purpose of this FOA is to provide support for applications that propose a novel genome editing clinical trial that includes at least two different diseases, using the same genome editor, route of administration, and delivery system.
Letter of Intent Deadline: October 7, 2022
Application Deadline: November 10, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-RM-22-016.html
NIDDK Funding Opportunity Application Due: Early-Stage Preclinical Validation of Therapeutic Leads for Diseases of Interest to the NIDDK (R01 Clinical Trial Not Allowed)
The goal of this Funding Opportunity Announcement (FOA) is to support translational research that provides strong justification for later stage therapeutics development and preclinical efforts in health-related outcomes relevant to the National Institute of Diabetes and Digestive and Kidney Diseases. This includes outcomes relevant to diabetes and other endocrine and metabolic diseases, liver and other digestive diseases, nutritional disorders, obesity, kidney and urological diseases, and hematologic diseases. Additional information concerning programmatic areas at NIDDK is available at www.niddk.nih.gov/research-funding/research-programs and applicants are strongly encouraged to discuss research priorities with the Scientific Contacts for each division.
The objective of this FOA is to stimulate early-stage preclinical validation of therapeutic leads (that need not be finalized therapeutics, henceforth called "therapeutic leads") such as small molecules or non-viral biologics that are not currently a focus within the biotechnology and pharmaceutical industries. It is expected that there is significant novelty in the target, small molecule, or non-viral biologic and in how the resulting therapeutic would differentiate from existing therapies. This must be articulated clearly in the application. It is not intended to support research focused on understanding normal biology, disease processes, generating lists of putative new targets, identifying new therapeutic uses for existing compounds, or identifying mechanism of action for therapeutic leads.
Letter of Intent Deadline: June 14, 2022, ; October 14, 2022, (...)
Application Deadline: July 14, 2022 ; November 14, 2022, (...)
More Information: https://grants.nih.gov/grants/guide/pa-files/par-22-111.html
NIDDK Funding Opportunity: Notice of Special Interest to Encourage Eligible NIH HEAL Initiative Awardees to Apply for PA-20-222: Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed) Application Due Date
Description: The NIH has a strong interest in the diversity of the NIH-funded research enterprise (see NIH notice NOT-OD-20-031) and encourages institutions to diversify their scientific workforce by increasing the participation of individuals from groups identified as underrepresented in the biomedical, clinical, behavioral, and social sciences. Participating institutes continue to support these efforts through ongoing programs and supplement funding opportunities. This specific notice reiterates this interest and encourages eligible grant and cooperative agreement awardees in the HEAL Initiative community to apply for administrative supplements in response to PA-20-222 (or any subsequent reissuances), Research Supplements to Promote Diversity in Health-Related Research (Admin Supp - Clinical Trial Not Allowed). This notice is part of the NIH’s Helping to End Addiction Long-term (HEAL) Initiative to speed scientific solutions to the national opioid public health crisis. The NIH HEAL Initiative is a trans-NIH effort to (1) improve prevention and treatment strategies for opioid misuse and addiction and (2) enhance pain management. More information about the HEAL Initiative is available at: https://heal.nih.gov/.
More Information: https://grants.nih.gov/grants/guide/notice-files/not-ns-20-107.html
NIDDK Funding Opportunity Application Due: Type 1 Diabetes Mellitus Stakeholder Engagement Innovation Center to Advance Health Equity (U2C Clinical Trial Not Allowed)
This U2C funding opportunity announcement (FOA) is a National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) initiative to establish a novel national Stakeholder Engagement Innovation Center for advancing equity in type 1 diabetes research (SEIC-T1D). A primary goal of the SEIC-T1D is to accelerate equitable engagement of diverse stakeholders (specifically people from NIH designated health disparities populations) in T1D research; particularly those from communities that experience diabetes-related health disparities and live within the healthcare and social systems that negatively impact community members’ and patients’ health. The SEIC-T1D will provide highly specialized research resources to support investigators by fully embedding communities, people living with T1D, and other stakeholders into the full spectrum of research activities through expert consultations and education in principles and methods of community-engaged research. The SEIC-T1D will also establish a network consisting of diverse, multidisciplinary research investigators with expertise in T1D and community-engaged methods, community experts with lived experiences, and representatives of various health and other organizations deemed essential for addressing disparities and advancing health equity in T1D early detection and treatment.
Letter of Intent Deadline: October 17, 2022
Application Deadline: November 17, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/RFA-DK-22-019.html
Nov. 17, 2022
NIH Funding Opportunity Application Due: Interventions that Address Structural Racism to Reduce Kidney Health Disparities – Research Coordinating Center (U24 - Clinical Trial Not Allowed)
The Interventions that Address Structural Racism to Reduce Kidney Health Disparities Consortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. The Consortium will consist of one Research Coordinating Center and multiple Intervention Sites (see RFA-DK-22-014) that will work collaboratively to develop, implement and evaluate meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities. This Funding Opportunity Announcement (FOA) invites applications for the Research Coordinating Center (RCC) that will lead, manage, and harmonize efforts for the Consortium. The specific activities of the RCC will include: 1) providing organization, management, and administrative support of Consortium activities; 2) providing research coordination, data management and data analyses for Consortium studies; and 3) fostering research collaborations and helping to build a community of investigators with skills to develop, implement, and disseminate effective, scalable, and sustainable interventions that address the structural drivers of kidney health disparities.
Letter of Intent Deadline: October 17, 2022
Application Deadline: November 17, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-015.html
Nov. 17, 2022
NIH Funding Opportunity Application Due: Interventions that Address Structural Racism to Reduce Kidney Health Disparities - (U01 - Clinical Trial Required)
The Interventions that Address Structural Racism to Reduce Kidney Health Disparities Consortium aims to foster community-engaged intervention research to address structural racism to reduce health disparities among individuals living with kidney disease. This Funding Opportunity Announcement (FOA) invites applications for Intervention Sites that will work collaboratively with a Research Coordinating Center (RCC) (see RFA-DK-22-015) to develop and test meaningful interventions that aim to dismantle or mitigate the effects of structural racism to reduce kidney health disparities. Studies proposed by the successful applicants may be substantially revised prior to being undertaken by the Consortium, including the potential of harmonizing intervention components and data collection measures across Intervention Sites.
Letter of Intent Deadline: October 17, 2022
Application Deadline: November 17, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-014.html
NIDDK Funding Opportunity Letter of Intent Due: Understanding the Pathophysiology and Clinical Course of New-Onset Diabetes Following COVID-19 (U01 Clinical Trial Not Allowed)
This Funding Opportunity Announcement invites multiple Program Director/Principal Investigator (multi-PD/PI) applications to conduct a study to establish a longitudinal cohort of individuals who developed diabetes following SARS-CoV-2 infection to understand the pathophysiology and clinical course post-COVID-19 diabetes. The cohort must include children and adults and reflect the geography and demographics of COVID-19 in the U.S. There must be an appropriate comparator population recruited and followed. The goals are to determine the contribution of: 1) specific pathophysiologic pathways; 2) overall health impact of the pandemic; 3) COVID-19 severity, and 4) COVID-19 treatment upon excess new onset diabetes from SARS-CoV-2 infection and response to diabetes therapy.
Letter of Intent Deadline: November 20, 2022
Application Deadline: December 20, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-016.html
NIDDK Funding Opportunity Application Due: KUH Predoctoral to Postdoctoral Fellow Transition Award (F99/K00 - Independent Clinical Trial Not Allowed)
The purpose of the Kidney, Urology or Hematology (KUH) Predoctoral to Postdoctoral Transition Award (F99/K00) is to recruit truly exceptional graduate students, who are currently not involved in Kidney, Urology or Hematology (K, U or H) research, and provide them a stable transition into a postdoctoral research experience focused on K, U, or H research. Strong candidates will bring novel approaches and diverse perspectives from fields including, but not limited to, engineering, statistics, data science, imaging, biochemistry, neuroscience and genetics. Graduate students who are already involved in K, U, or H research are not eligible for this F99/K00 award and are instead encouraged to apply for the Ruth L. Kirschstein National Research Service Award (NRSA) Individual Predoctoral Fellowship (Parent F31, PA-21-051). Prospective applicants are strongly encouraged to contact the NIDDK Program Official early in the process to discuss eligibility and program goals.
Application Deadline: August 1, 2022; November 30, 2022; March 30, 2023 (...)
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-21-033.html
Nov. 30, 2022
NIDDK Funding Opportunity Application Due: Helping to Accelerate Research Potential (HARP) (UE5 - Clinical Trial Not Allowed)
The NIH Research Education Cooperative Agreements Program (UE5) supports research education activities in the mission areas of the NIH. The overarching goal of this Helping to Accelerate Research Potential (HARP) UE5 program is to complement and/or enhance the training of a workforce to meet the nation’s biomedical, behavioral and clinical research needs. The main objective of the HARP UE5 program is to provide opportunities and mentorship for current NIDDK grantees, especially postdoctoral scholars and junior faculty from diverse backgrounds, to enhance their skills in areas that are critical for establishing and maintaining successful independent academic research careers. To accomplish the stated overarching goal, this FOA will support creative educational activities with a primary focus on: Courses for Skills Development; Mentoring Activities. The HARP UE5 program aims to develop a network of mentors and scholars, with the expectation that scholars will apply for a career stage-appropriate NIH research project grant (e.g., R01 or R01-equivalent grant for junior faculty scholars; K grant for postdoctoral scholars) after their participation in the program. The scholars of the HARP UE5 program will be assigned by NIDDK staff and UE5 recipients will not be responsible for the recruitment of scholars.
Letter of Intent Deadline: October 30, 2022
Application Deadline: November 30, 2022
More Information: https://grants.nih.gov/grants/guide/rfa-files/rfa-dk-22-002.html
Travel Grants Application Deadline: CureGN Analytic Workshop
Workshop Date: Jan. 17-18, 2023. Workshop goals: 1) Increase visibility of CureGN 2) Increase the capacity to access and analyze CureGN data among the research community 3) Increase bandwidth for publications and ancillary studies 4) Support career development. Early-career investigators and their trainees who are interested in attending the CureGN Analytic Workshopare eligible to apply for a travel grant to support the costs of travel and lodging of up to $500 (based onavailability). Up to 8 awardees will be selected.
